Superworth

Fulgent Genetics EPS FLGT

Diluted earnings per share by quarter and over the last twelve months, from 2015.

Last 12 months, to Jun 30, 2026
−$2.82
Latest quarter, Q2 FY26
−$1.05
Fiscal year 2025
−$1.96

Fulgent Genetics' earnings per share was −$2.82 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.05.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.96n/a
FY2024−$1.41n/a
FY2023−$5.64−224%
FY2022$4.56−72%
FY2021$16.38+100%
FY2020$8.19n/a
FY2019−$0.01n/a
FY2018−$0.31n/a
FY2017−$0.14n/a
FY2016−$1.10n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.05n/a−$2.82
Q1 FY26−$0.80n/a−$2.39
Q4 FY25−$0.76n/a−$1.96
Q3 FY25−$0.21n/a−$1.39
Q2 FY25−$0.62n/a−$1.66
Q1 FY25−$0.37n/a−$1.33
Q4 FY24−$0.19n/a−$1.41
Q3 FY24−$0.48n/a−$5.52
Q2 FY24−$0.29n/a−$5.48
Q1 FY24−$0.45n/a−$5.57
Q4 FY23−$4.30n/a−$5.64
Q3 FY23−$0.44−833%−$2.14

Against its peers

Companies in Medical - Diagnostics & Research nearest Fulgent Genetics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
FLGTFulgent Genetics−$2.82
NRCNRC Health$0.25−67% a year
ICCCImmucell$0.08−58% a year
CDNACareDx$2.07+116% a year
VCYTVeracyte$1.40+324% a year
BLLNBillionToOne$0.65
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Fulgent Genetics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.